OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
The latest news and technology advances for drug dosage forms.
Fatty alcohols may enhance the skin permeation of clotrimazole.
The right partner can help companies overcome key formulation challenges.
Plasma-based proteins and cell-based therapies can address unmet medical needs.
March 03, 2021
With funding from the federal government, Merck will expand capacity to produce J&J’s COVID-19 vaccine.
In a pandemic, genetic vaccines offer several advantages over traditional approaches.
RDIF has announced that the Sputnik V vaccine for COVID-19 has been approved in Slovakia under the emergency use authorization procedure.
March 01, 2021
Distribution of the first one-dose vaccine for COVID-19 to start in early March.
February 23, 2021
Aprecia's compression-free 3DP manufacturing platform and Glatt’s multiparticulate technologies offer solutions to pharmaceutical dosage design challenges.
February 17, 2021
The EC has granted marketing authorization to Celltrion Healthcare for its adalimumab biosimilar, Yuflyma (CT-P17).
February 03, 2021
Rapid growth in biologics and increasing complexity of new compounds are some of the factors driving development of innovative delivery solutions.
Advanced manufacturing technologies are available, but challenges need to be addressed.
February 02, 2021
The EC intends to get tougher on issues such as reliability of drug supplies, particularly essential medicines.
February 01, 2021
Best practices can help ensure supply chain flexibility and viability for biologic drugs in clinical trials.